The Supreme Court's Latest Ruling on Drug Liability and its Implications for Future Failure-to-Warn Litigation

Christopher J Morten¹, Aaron S Kesselheim¹, Joseph S Ross¹

• ¹Christopher J. Morten, J.D., Ph.D., is a Fellow of the Engelberg Center on Innovation Law & Policy and the Teaching Fellow and Supervising Attorney in the Technology Law & Policy Clinic at New York University School of Law. He is also a Visiting Fellow of the Information Society Project at Yale Law School. He received his JD from NYU Law, a PhD in organic chemistry from the Massachusetts Institute of Technology, and a BA in chemistry from Columbia University. Aaron S. Kesselheim, M.D., J.D., M.P.H., is a Professor of Medicine at Harvard Medical School and Director of the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital. His work is funded by Arnold Ventures, the Harvard-MIT Center for Regulatory Science, and the Engelberg Foundation. Joseph S. Ross, M.D., M.H.S., is a Professor of Medicine (General Medicine) and of Public Health (Health Policy and Management) at the Yale School of Medicine, a member of the Center for Outcomes Research and Evaluation at Yale-New Haven Health System, and Co-Director of the National Clinician Scholars Program at Yale.